Patients with eosinophilia were thought to have gastroesophageal reflux disease (GERD) but did not respond to medical and/or surgical GERD management.
Subsequent studies demonstrated that these patients had a ‘new' disease termed eosinophilic esophagitis.
|Symptoms included, but were not restricted to food impaction and dysphagia|
As recognition of eosinophilic esophagitis grew, so did confusion surrounding diagnostic criteria and treatment.
Dr Glenn Furuta and a multidisciplinary task force of 31 physicians assembled to determine diagnostic criteria of children and adults with suspected eosinophilic esophagitis.
The team also made recommendations for evaluation and treatment of the condition.
Consensus recommendations were based upon a systematic review of the literature and expert opinion.
The team reported that eosinophilic esophagitis is a clinicopathological disease characterized by 3 main factors.
Symptoms included, but were not restricted to, food impaction and dysphagia in adults, and feeding intolerance in adults and GERD symptoms in children.
The presence of eosinophils, and the exclusion of other disorders associated with similar clinical, histological, or endoscopic features, especially GERD were also diagnostic.
The investigative team noted that appropriate treatments include dietary approaches based upon eliminating exposure to food allergens, or topical corticosteroids.
Dr Furuta's team concluded, "Since eosinophilic esophagitis is a relatively new disease, the intent of this report is to provide current recommendations for care of affected patients and defining gaps in knowledge for future research studies."